ARCHIVES

Zydelig Tablets Approved For Three Blood Cancers

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

ODAC Says Clear Clinical Benefit Required When Sponsors Claim Progression Delay

July 17, 2009

Guest Editorial – Interlocking Tragedies: Lance Armstrong and CPRIT

February 15, 2013

ACS Reorganization Plans, Policy Changes Discussed By Board

November 29, 1991

NCI Plans $40M In Grants For Cancer Outcomes Studies.

June 30, 2000

Why Did DeVita Resign MSK Post? Clash Of Style, Other Serious Issues Pointed To By Colleagues

June 7, 1991

Review Of Cancer, AIDS Drugs Starts At Jan. Meeting

December 2, 1988